169 related articles for article (PubMed ID: 38314381)
1. Unveiling Variations: A Comprehensive Comparison of Five Globally Used Thyroid Cytology Reporting Systems With Histopathological Correlation.
Ramamoorthy S; Boddapati A; Venkata Renuka I; Imandi S; Mounica B
Cureus; 2024 Feb; 16(2):e53359. PubMed ID: 38314381
[TBL] [Abstract][Full Text] [Related]
2. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.
Guerreiro SC; Tastekin E; Mourao M; Loureiro I; Eusebio R; Marques HP; Oznur M; Caliskan CK; Schmitt FC; Bongiovanni M; Canberk S
Acta Cytol; 2023; 67(6):593-603. PubMed ID: 37899024
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
4. A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.
Arul P; Akshatha C; Masilamani S
Biomed J; 2015 Dec; 38(6):517-22. PubMed ID: 27013451
[TBL] [Abstract][Full Text] [Related]
5. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More.
Bagıs M; Can N; Sut N; Tastekin E; Erdogan EG; Bulbul BY; Sezer YA; Kula O; Demirtas EM; Usta I
Endocr Pathol; 2024 Mar; 35(1):51-76. PubMed ID: 38280141
[TBL] [Abstract][Full Text] [Related]
7. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution.
Mehra P; Verma AK
Patholog Res Int; 2015; 2015():240505. PubMed ID: 25688327
[TBL] [Abstract][Full Text] [Related]
9. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
Kim M; Kim JE; Kim HJ; Chung YR; Kwak Y; Park SY
J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of "The Bethesda System for Reporting Thyroid Cytopathology:" A Retrospective Analysis of 107 Patients.
Awasthi P; Goel G; Khurana U; Joshi D; Majumdar K; Kapoor N
J Cytol; 2018; 35(1):33-36. PubMed ID: 29403167
[TBL] [Abstract][Full Text] [Related]
11. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
[TBL] [Abstract][Full Text] [Related]
12. Thyroid cytopathology with an emphasis on the 'atypical cells of uncertain significance' category: a 3-year audit with cytohistologic correlation.
Fatman L; Michelow P
Acta Cytol; 2015; 59(1):17-25. PubMed ID: 25612652
[TBL] [Abstract][Full Text] [Related]
13. Interobserver variability in inconclusive diagnostic categories of thyroid fine needle aspiration cytology: An urban-based tertiary hospital experience.
Sripodok S; Benjakul N
Ann Diagn Pathol; 2023 Apr; 63():152083. PubMed ID: 36657263
[TBL] [Abstract][Full Text] [Related]
14. Risk of malignancy in Thyroid "Atypia of undetermined significance/Follicular lesion of undetermined significance" and its subcategories - A 5-year experience.
Thakur A; Sarin H; Kaur D; Sarin D
Indian J Pathol Microbiol; 2019; 62(4):544-548. PubMed ID: 31611437
[TBL] [Abstract][Full Text] [Related]
15. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
[TBL] [Abstract][Full Text] [Related]
16. Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand.
Thewjitcharoen Y; Butadej S; Nakasatien S; Chotwanvirat P; Porramatikul S; Krittiyawong S; Lekpittaya N; Himathongkam T
J Clin Transl Endocrinol; 2019 Jun; 16():100175. PubMed ID: 30815363
[TBL] [Abstract][Full Text] [Related]
17. Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology - An Institutional Experience of 5 Years.
Upadhyaya P; Dhakal S; Adhikari P; Adhikari B; Khadka D; Niraula SR
J Cytol; 2019; 36(1):48-52. PubMed ID: 30745740
[TBL] [Abstract][Full Text] [Related]
18. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
19. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
[TBL] [Abstract][Full Text] [Related]
20. Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAF
Chirayath SR; Pavithran PV; Abraham N; Nair V; Bhavani N; Kumar H; Menon UV; Menon AS
Indian J Endocrinol Metab; 2019; 23(3):278-281. PubMed ID: 31641627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
